JPMORGAN CHASE & CO

Position in AYTU — Aytu Biopharma, Inc

CIK 19617 NEW YORK, NY

Position in AYTU

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$331

-$89 QoQ

Shares Held

154

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#24

of 38 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. AYTU ranks #57 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	6,398,674	$1,078,432,506
2	TEVA	Teva Pharmaceutical Industries Ltd	6,981,234	$236,524,202
3	ZTS	Zoetis Inc.	2,624,825	$188,619,917
4	HIMS	Hims & Hers Health, Inc.	4,766,781	$165,264,292
5	UTHR	UNITED THERAPEUTICS Corp	275,358	$149,197,220
6	VTRS	Viatris Inc	7,322,267	$116,277,595
7	HLN	Haleon plc	10,824,395	$100,991,599
8	LNTH	Lantheus Holdings, Inc.	699,229	$77,572,458

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$331	154	0.0%	Shares	Defined	2026-08-12
2026-03-31	$420	154	+105.3%	Shares	Defined	2026-05-13
2024-12-31	$127	75	-76.0%	Shares	Defined	2025-02-12
2024-09-30	$735	313	-42.0%	Shares	Defined	2024-12-26
2024-06-30	$1,576	540	-12.9%	Shares	Defined	2024-12-26
2024-03-31	$1,884	620	-90.9%	Shares	Defined	2024-12-26
2023-12-31	$19,411	6,835	+212.4%	Shares	Defined	2024-12-26
2023-09-30	$5,907	2,188	+272.7%	Shares	Defined	2023-11-14
2023-06-30	$939	587	-98.9%	Shares	Defined	2023-08-11
2021-03-31	$420,925	55,385	+634.8%	Shares	Defined	2021-05-12
2020-12-31	$45,071	7,537	-78.5%	Shares	Defined	2021-02-19
2020-09-30	$41,620	34,976	+66.3%	Shares	Defined	2020-11-12
2020-06-30	$29,865	21,032	—	Shares	Defined	2020-08-11
No filing history on record for this holder in this stock.